Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Feb 6:2024:7501577.
doi: 10.1155/2024/7501577. eCollection 2024.

Homozygous Sickle Cell Disease after Age of 40: Follow-Up of a Cohort of 209 Patients in Senegal, West Africa

Moussa Seck  1   2 , Maureen Adéniké Dabo  2 , Elimane Seydi Bousso  2 , Mohamed Keita  2 , Sokhna Aïssatou Touré  1   2 , Sérigne Mourtalla Guèye  2 , Blaise Félix Faye  1   2 , Fatma Dieng  2 , Saliou Diop  1   2
Affiliations

Homozygous Sickle Cell Disease after Age of 40: Follow-Up of a Cohort of 209 Patients in Senegal, West Africa

Moussa Seck et al. Adv Hematol. .

Abstract

Objectives: The aim of this study was to describe the morbidity and mortality of homozygous sickle cell disease after the age of 40.

Methods: This was a cohort study of 209 patients followed from 1994 to 2022. All hemoglobin electrophoresis-confirmed SS sickle cell patients over 40 years were included. A descriptive study of epidemiological, diagnostic, therapeutic, and evolutionary data was used to assess morbidity and mortality.

Results: Sex ratio (M/F) was 0.6. Median age was 47 (41-75). According to morbidity, 95.1% had less than 3 vaso-occlusive crises/year. Acute anemia was the most frequent complication (52.63%). Chronic complications were noted in 32.5%. At diagnosis, mean hemoglobin was 8.1 g/dl ± 1.9, HbS was 86.5 ± 10, and HbF was 9.4 ± 7.6. Number of patients transfused was 66%. We noted that 8.1% of patients died, 29.2% were lost to follow-up, and 62.7% were still being followed up. The risk factors identified for death were geographical origin, comorbidity, high HbS, low HbF, and thrombocytosis.

Conclusion: This study shows that homozygous SCD is increasingly becoming an adult disease and that it can be carried into old age in Africa. Advanced age over 40 is marked by an upsurge in chronic complications, making it essential to set up a screening program and to organize multidisciplinary follow-up.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Figures

Figure 1
Figure 1
Distribution of sickle cell patients by age and gender.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Rees D. C., Williams T. N., Gladwin M. T. Sickle-cell disease. The Lancet . 2010;376(9757):2018–2031. doi: 10.1016/s0140-6736(10)61029-x. - DOI - PubMed
    1. Ngo Sack F., Seck M., Diop S. Morbidité et Aspects Evolutifs de la Drépanocytose SC: une Étude de 129 Patients au Service d’Hématologie Clinique de Dakar. Health Sciences and Disease . 2016;17(4):p. 6.
    1. Diop S., Diop D., Seck M., et al. [Predictive factors of chronic complications in adult sickle cell anemia patients in Dakar, Senegal] Medecine Tropicale . 2010;70(5-6):471–474. - PubMed
    1. Dhédin N., Paillard C., Dalle J. H., et al. Allogreffe de cellules souches hématopoïétiques dans la drépanocytose de l’enfant et de l’adulte: indications et modalités. Bulletin du Cancer . 2020;107(9):925–933. doi: 10.1016/j.bulcan.2020.06.003. - DOI - PubMed
    1. Brousse V., Bernaudin F., Melaine A., et al. Severity and burden of sickle cell disease in France: a nationwide real-world study. Haematologica . 2023;108(9):2476–2486. doi: 10.3324/haematol.2022.282098. - DOI - PMC - PubMed

LinkOut - more resources